Physiotherapeutic conduct in amyotrophic lateral sclerosis

Sao Paulo Medical Journal

Volumn 124, Issue 6, 2006, Pages 350-354

  Pozza, Andreza Martinez ^a   Delamura, Milene Karenine ^a   Ramirez Tognola, Clarissa ^a,c   Valério, Nelson Iguimar ^a   Marino, Laís Helena Carvalho ^a,b   Lamari, Neuseli Marino ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b HOSPITAL DE BASE   (Brazil)

^c Hospital de Base de São José do Rio Preto ^*  (Brazil)

Author keywords

Amyotrophic lateral sclerosis; Breathing exercises; Neurodegenerative diseases; Quality of life; Rehabilitation

Indexed keywords

ALPHA TOCOPHEROL; CREATINE; RILUZOLE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTIFICIAL VENTILATION; BODY POSTURE; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; IMMOBILIZATION; KINESIOTHERAPY; MUSCLE FATIGUE; MUSCLE STRETCHING; MUSCLE TRAINING; PATIENT CARE; PATIENT MONITORING; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; BREATHING EXERCISES; FATIGUE; HUMANS; PHYSICAL THERAPY MODALITIES; QUALITY OF LIFE; RESPIRATORY INSUFFICIENCY;

EID: 33947167822     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802006000600011     Document Type: Review

References (34)

1. Wicklund MP. Amyotrophic lateral sclerosis: possible role of environmental influences. Neurol Clin. 2005;23(2): 461-84.
2. Belsh JM. Diagnostic challenges in ALS. Neurology. 1999;53(8 Suppl 5):S26-30; discussion S35-6.
3. Majoor-Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet. 2003;63(2):83-101.
4. Kirby J, Halligan E. Baptista MJ, et al. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain. 2005; 128(Pt 7):1686-706.
5. Shipe C, Zivkovic SA. Electrodiagnostic evaluation of motor neuron disorders. Am J Electroneurodiagnostic Technol. 2004,44(1):30-6.
6. González-Lorenzo F, Díaz-Lobato S. Soporte ventilatorio en pacientes con esclerosis lateral amiotrófica. [Mechanical ventilation in patients with amyotrophic lateral sclerosis.] Rev Neurol. 2003;30(1):61-4.
7. Dal Bello-Hass V, Kloos AD, Mitsumoto H. Physical therapy for a patient through six stages of amyotrophic lateral sclerosis. Phys Ther. 1998;78(12):1312-24.
8. Dietrich-Neto F, Callegaro D, Dias-Tosta E, et al. Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Arq Neuropsiquiatr. 2000;58(3A):607-15.
9. Pouget J, Azulay JP, Bille-Turc F, Sangla I, Serratrice GT. The diagnosis of amyotrophic lateral sclerosis. Adv Neurol. 1995;68:143-52.
10. Le Forestier N. Diagnostics différentiels de la sclerose latérale amyotrophique. [The differential diagnosis of amyotrophic lateral sclerosis]. Rev Med Liege. 2004;59(Sppl 1):25-31.
11. McGeer EG, McGeer PL. Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis. BioDrugs. 2005;19(1):31-7.
12. Ellis AC, Rosenfeld J. The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders. CNS Drug,. 2004;18(14):967-80.
13. Ascherio A, Weisskopf MG, O'Reilly EJ, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Am Neurol. 2005;57(1):104-10.
14. Gómez, Fernándrz L, Calzada Sierra DJ. Importancia del tratamiento rehabilitador multifactorial en la esclerosis lateral amiotrófica. [The importance of multifactorial rehabilitation treatment in amyotrophic lateral sclerosis]. Rev Neurol. 2001; 32(5):423-6.
15. Piemonte MEP, Ramirez C. Como este manual pode ajudar. Piemonte MEP, editor. Manual de exercícios domiciliares para pacientes com esclerose lateral amiotrófica. São Paulo: Manole; 2001. p. 19-64.
16. Pedroso JPC, Ramirez C, Silva HCA, et al. Importance of the physical therapeutic program in muscular force and the functional state in patients with amyotrophic lateral sclerosis during 6 months. Proceedings of the 12th International Symposium on ALS/MND; 2001 Nov 18-20; Oakland, USA; 2001. p. 94.
17. Duran MA, Reis RG, Oliveira ASB. et al. Orientations of the motor physiotherapy to the caregivers, relatives and patients with ALS. Arq Neuropsiquiatr. 2002;60(Supl 1). [abstract].
18. Drory VE. Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;191(1-2);133-7.
19. Haerer AF. DeJong's neurologic examination. 5th ed. Philadelphia: JB Lippincott Company; 1992.
20. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206-7.
21. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol. 1996;53(2):141-7.
22. Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res. 1993;37(7):753-62.
23. Cohen SR. Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliar Med. 1995;9(3):207-19.
24. Wallerstein SL. Scaling clinical pain and pain relief. In: Bromm B, editor. Pain measurement in man: neurophysiological correlates of pain, New York: Elsevier; 1984.
25. Ramirez C. Fadiga na esclerose lateral amiotrófica: freqüência e fatores associados. [Fatigue in amyotrophic lateral sclerosis: associated factors and frequency]. [dissertation]. São Paulo: Faculdade de Medicina da Universidade de São Paulo; 2004.
26. Van den Berg-Vos RM, Visser J, Franssen H, de Visser M, Wokke JHJ, Van den Berg LH. Sporadic lowor mow neuron disease with adult onset: classification of subtypes. Proceedings of the 12th International Symposium on ALS/MND; 2001 No, 18-20; Oakland, USA; 2001. p. 42.
27. Scarmeas, N. Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59(5):773-5.
28. Chio A, Benzi G, Dossena M, Mutani R. Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128(Pt 3):472-6.
29. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. ALS Practice Parameters Task Force. Neurology. 1999;52(7): 1311-23.
30. Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164(1):82-8.
31. Brooks BR. El Escorial World Federation of Neurology critaria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors, J Neurol Sci. 1994;124(Suppl):96-107.
32. Pinto AC, Evangelista T, de Carvalho M, Paiva T. de Lurdes Sales-Luis M. Respiratory disorders in ALS: sleep and exercise studies. J Neurol Sci. 1999;169(1-2):61-8.
33. Bourke Sr, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003;61(2):171-7.
34. Bathlen GM, Lange DJ. Unexpectedly severe sleep and respiratory pathology in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2000;7(3):299-302.